Skip to main content

CAPTRUST FINANCIAL ADVISORS

Position in ANTX — AN2 Therapeutics, Inc.

CIK 1512024 RALEIGH, NC

Position in ANTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$194,398
+$57,598 QoQ
Shares Held
40,165
+0.4% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 66 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. ANTX ranks #69 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ANTX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $194,398 40,165
2026-03-31 $136,800 40,000
2025-12-31 $45,600 40,000
2025-09-30 $50,800 40,000
2025-06-30 $42,400 40,000
2025-03-31 $13,600 10,000
2024-12-31 $39,560 28,667
2024-09-30 $30,673 28,667
2024-06-30 $61,634 28,667
2024-03-31 $93,167 28,667
2023-12-31 $587,386 28,667
2023-09-30 $460,965 28,667